Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue Inflammatory Bowel Diseases Année : 2022

Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID

Catherine Reenaers
Arnaud de Roover
  • Fonction : Auteur
Laurent Kohnen
  • Fonction : Auteur
Marion Simon
  • Fonction : Auteur
Guillaume Pourcher
  • Fonction : Auteur
Caroline Trang-Poisson
  • Fonction : Auteur
Sylvie Rajca
  • Fonction : Auteur
Simon Msika
  • Fonction : Auteur
Stéphanie Viennot
  • Fonction : Auteur
Romain Alttwegg
  • Fonction : Auteur
Mélanie Serrero
  • Fonction : Auteur
Philippe Seksik
  • Fonction : Auteur
Laurence Picon
  • Fonction : Auteur
Céline Bourbao Tournois
  • Fonction : Auteur
Renaud Gontier
  • Fonction : Auteur
Cyrielle Gilletta
  • Fonction : Auteur
Carmen Stefanescu
  • Fonction : Auteur
David Laharie
  • Fonction : Auteur
Xavier Roblin
  • Fonction : Auteur
Stéphane Nahon
  • Fonction : Auteur
Guillaume Bouguen
  • Fonction : Auteur
Franck Carbonnel
Alain Attar
  • Fonction : Auteur
Edouard Louis
  • Fonction : Auteur
Benoît Coffin
  • Fonction : Auteur

Résumé

Abstract Background The prevalence of obesity and the number of bariatric surgeries in both the general population and in patients with inflammatory bowel disease (IBD) have increased significantly in recent years. Due to small sample sizes and the lack of adequate controls, no definite conclusions can be drawn from the available studies on the safety and efficacy of bariatric surgery (BS) in patients with IBD. Our aim was to assess safety, weight loss, and deficiencies in patients with IBD and obesity who underwent BS and compare findings to a control group. Methods Patients with IBD and a history of BS were retrospectively recruited to centers belonging to the Groupe d’Etude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID). Patients were matched 1:2 for age, sex, body mass index (BMI), hospital of surgery, and type of BS with non-IBD patients who underwent BS. Complications, rehospitalizations, weight, and deficiencies after BS were collected in cases and controls. Results We included 88 procedures in 85 patients (64 Crohn’s disease, 20 ulcerative colitis, 1 unclassified IBD) with a mean BMI of 41.6 ± 5.9 kg/m2. Bariatric surgery included Roux-en-Y gastric bypass (n = 3), sleeve gastrectomy (n = 73), and gastric banding (n = 12). Eight (9%) complications were reported, including 4 (5%) requiring surgery. At a mean follow-up of 34 months, mean weight was 88.6 ± 22.4 kg. No difference was observed between cases and controls for postoperative complications (P = .31), proportion of weight loss (P = .27), or postoperative deficiencies (P = .99). Conclusions Bariatric surgery is a safe and effective procedure in patients with IBD and obesity; outcomes in this patient group were similar to those observed in a control population.
Fichier non déposé

Dates et versions

hal-04168206 , version 1 (21-07-2023)

Identifiants

Citer

Catherine Reenaers, Arnaud de Roover, Laurent Kohnen, Maria Nachury, Marion Simon, et al.. Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID. Inflammatory Bowel Diseases, 2022, 28 (8), pp.1198-1206. ⟨10.1093/ibd/izab249⟩. ⟨hal-04168206⟩
19 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More